Stockreport

Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update [Yahoo! Finance]

Reneo Pharmaceuticals, Inc.  (RPHM) 
PDF development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today reported financial results for the fourth quarter and year en [Read more]